tradingkey.logo
tradingkey.logo
Search

Faeth Therapeutics Ord Shs

FTH
Add to Watchlist
24.000USD
+0.810+3.49%
Close 06/23, 16:00ETQuotes delayed by 15 min
32.17MMarket Cap
--P/E TTM
You can find the annual or quarterly income statement of Faeth Therapeutics Ord Shs here for insights into the performance and operational efficiency of Faeth Therapeutics Ord Shs.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
Operating expenses
--37.67M
R&D expenses
--17.96M
Depreciation, depletion, and amortization
--30.00K
Operating profit
---37.67M
Net non-operating interest income (expenses)
Non-operating interest income
--392.00K
Special income (expenses)
---132.96M
Other non-operating income (expenses)
--1.00K
Income before tax
---170.23M
Income tax
--0.00
Income after tax
---170.23M
Net income from continuous operations
---170.23M
Net income attributable to controlling interests
---170.24M
Net income attributable to common shareholders
---170.24M
Basic earnings per share
---131.45
Diluted earnings per share
---131.45
Dividend per share
--0.00
Currency unit
USD
Audit opinions
--

FAQs

What is the income statement?

The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.
KeyAI